Congratulations to @RadAI, winner of the Medical Imaging Analysis category in Newsweek's inaugural AI Impact Health Awards.

But Revela goes beyond reading images. It keeps every photograph beside the patient's own verdict on the result.

The patient is still in the consultation chair when the photographs go into the record.

The surgeon picks up an iPad, opens a face template, and sketches over it, marking what the two of them just discussed. The drawing, the images and the exam notes all sit together.

No algorithm reads the photographs and returns a diagnosis.

What will they show at the outcome visit months from now?

Those photographs are medical images, and images are where healthcare AI has concentrated most heavily. A peer-reviewed analysis published July 13, 2026 examined all 1,430 AI and machine-learning device authorizations the FDA recorded between September 1995 and December 2025. Devices reviewed by the Radiology panel accounted for 1,094 of them, or 76.5 percent.

That's a crowded, fast-moving and heavily regulated field, and specialist imaging companies do important work in it. So what does a clinical network do if it isn't going to build image-reading AI?

This network made a clear choice: no proprietary diagnostic computer vision. It concentrates instead on the record the images belong to and on what happens to the patient over time. Revela carries the whole aesthetic and reconstructive journey: consultation photography, chairside drawing on face, breast and body templates, readiness and risk screening, procedural documentation and patient-reported outcome measures. After surgery, Companion carries the recovery on the same record.

That last piece matters most. In aesthetic and reconstructive care, the outcome is partly how the patient feels about the result. Recording that judgment in a structured way, next to the before-and-after images, lets a practice learn what actually worked for patients like this one.

There's a quieter point here for anyone thinking about where lasting value sits. Image-reading models compete in a field where new entrants arrive every quarter. A continuous record that links photographs, surgical documentation, recovery and the patient's own assessment of the outcome is far rarer, and it grows more informative with every case. A company that knows which field it's in can put all of its effort there.

The honest limit is real. A record-centered platform won't match specialist imaging companies at computer vision, and it shouldn't pretend to. The sensible stance is to receive and route their results into the patient's record.

So when you look at imaging in aesthetic care, ask where the patient's own verdict lives, and whether it sits beside the images that are supposed to explain it.